Graftless TSFE Via Self-tapping Implants

Recruiting now · Not applicable

Conditions studied: Edentulous Posterior Maxilla, Maxillary Sinus Pneumatization, Alveolar Bone Atrophy

In brief

This prospective clinical trial aims to evaluate the efficiency, safety, and reliability of a minimally invasive graftless transcrestal sinus lifting approach with simultaneous dental implant placement in patients with edentulous posterior maxilla and limited residual bone height. The study investigates bone formation beneath the Schneiderian membrane, implant stability, osseointegration, and long-term implant survival.

Key facts

Study ID

NCT07424742

Run by

Sana'a University

People needed

20

Starts

2024-09-09

Expected to finish

2026-09-09

Last updated by the study team

2026-06-02

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged 18-80 years.
• Patients with edentulous posterior maxilla.
• Residual bone height approximately 4-6 mm.
• Indicated for transcrestal sinus membrane elevation.
• Good general health (ASA I or II).
• Ability to provide written informed consent.
• Willingness to attend follow-up visits.

You may not qualify if…

• Severe systemic diseases (ASA III or above).
• Uncontrolled diabetes mellitus.
• Active sinus pathology.
• History of radiotherapy in the head and neck region.
• Heavy smokers (>10 cigarettes/day).
• Pregnancy or lactation.
• Untreated periodontal disease.
• Poor oral hygiene.

Where it is running

• Department of Oral and Maxillofacial Surgery, Sana'a University — Sanaa, Sanaa Governorate, Yemen (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.